We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1030 result(s) found, displaying 951 to 975
-
Market actions
-
Market actions
-
Safety alertsDo not use So Hard for Men tablets, Shaguar tablets, and Pulse8 for Women capsules as they contain undeclared tadalafil and are not approved. Consult your doctor if you have concerns.
-
Market actionsWeight loss drug Sibutramine (Reductil) withdrawn in Australia due to heart risks.
-
-
Safety alertsThe national immunisation program with Panvax® began on 30 September 2009. The TGA has been closely monitoring any side effects from the use of the vaccine.
-
Market actionsThe Therapeutic Goods Administration (TGA) has received enquiries about the recall of the LCS® DuofixTM Femoral Knee Replacement Component.
-
Safety alertsThe TGA is aware that the French authorities have now released an updated statement in regard to the testing of the PIP implants:
-
Safety alertsWe are analysing the safety of the Panvax H1N1 vaccine following reports of febrile convulsions in children.
-
Safety alertsWe are investigating febrile reactions in young children following the 2010 flu vaccine and have paused its use for kids under 5 in Western Australia.
-
Safety alerts
-
Market actionsThe Therapeutic Goods Administration (TGA) advises that Octapharma Australia Pty Ltd has agreed to a precautionary voluntary recall of all batches of Octagam intravenous immunoglobulin solutions from the Australian market.
-
Market actionsPanvax Junior is being recalled because of a drop in potency, and all available stocks are being removed.
-
Safety alerts
-
Safety alertsTesting on Australian Poly Implant Prothèse (PIP) samples of implants has been undertaken by TGA
-
Safety alertsConsumers are advised to stop using Hydroxycut products due to serious adverse reactions, including liver toxicity. We highlight differences between US and Australian formulations and recommend caution. Consult your doctor if concerned.
-
Safety alertsGardasil is a vaccine that protects young women from the strains of human papillomavirus (HPV) that cause 70% of cervical cancers.
-
Safety alertsStop using Viagra (sildenafil) 100mg tablets due to counterfeit concerns. Return them to your pharmacy and consult your doctor if you have any concerns.
-
Safety alertsContinuing investigation into issues with Poly Implant Prothèse (PIP) silicone gel-filled breast implants
-
Safety alertsRotavirus vaccines Rotarix and RotaTeq still recommended despite pig virus DNA fragments found.
-
Safety alertsWe are investigating adverse reactions to the 2010 flu vaccine in young children in Western Australia and have paused its use for kids under 5.
-
Market actionsMedical Visions Australia Pty Ltd following consultation with the Therapeutic Goods Administration is undertaking the recall of all non implanted silicone gel breast implants manufactured by Poly Implant Prothèse (PIP). The recall applies to all models of this type of implant.
-
-
Safety alertsConsumers are advised to stop using Hydroxycut products due to reports of serious adverse reactions, including liver toxicity, and to consult their doctor if they have any concerns.
-
Safety alertsBe aware that Hydroxycut products purchased via the internet may be sourced from the US and may contain ingredients which are not permitted in low-risk medicines in Australia